Marshall Wace’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-153,227
| Closed | -$5.09M | – | 3511 |
|
|
2022
Q4 | $5.09M | Buy |
153,227
+46,229
| +43% | +$1.49M | 0.01% | 1173 |
|
|
2022
Q3 | $3.37M | Sell |
106,998
-21,217
| -17% | -$687K | 0.01% | 1672 |
|
|
2022
Q2 | $3.9M | Buy |
128,215
+100,253
| +359% | +$2.71M | 0.01% | 1535 |
|
|
2022
Q1 | $726K | Buy |
+27,962
| New | +$665K | ﹤0.01% | 2598 |
|
|
2021
Q1 | – | Sell |
-126,430
| Closed | -$2.36M | – | 2988 |
|
|
2020
Q4 | $2.36M | Buy |
126,430
+37,483
| +42% | +$700K | 0.01% | 879 |
|
|
2020
Q3 | $1.51M | Buy |
+88,947
| New | +$1.73M | 0.01% | 889 |
|
|
2020
Q2 | – | Sell |
-167,361
| Closed | -$1.41M | – | 2062 |
|
|
2020
Q1 | $1.41M | Sell |
167,361
-324,673
| -66% | -$2.73M | 0.01% | 725 |
|
|
2019
Q4 | $4.81M | Buy |
492,034
+104,835
| +27% | +$984K | 0.03% | 547 |
|
|
2019
Q3 | $3.67M | Buy |
387,199
+74,313
| +24% | +$783K | 0.03% | 589 |
|
|
2019
Q2 | $3.72M | Buy |
312,886
+231,721
| +285% | +$2.79M | 0.03% | 581 |
|
|
2019
Q1 | $1.43M | Sell |
81,165
-158,223
| -66% | -$2.63M | 0.01% | 835 |
|
|
2018
Q4 | $4.16M | Buy |
+239,388
| New | +$4.08M | 0.04% | 506 |
|
|
2016
Q3 | – | Sell |
-12,587
| Closed | -$245K | – | 1184 |
|
|
2016
Q2 | $245K | Buy |
+12,587
| New | +$247K | ﹤0.01% | 918 |
|
|
2015
Q3 | – | Sell |
-75,021
| Closed | -$1.4M | – | 1098 |
|
|
2015
Q2 | $1.4M | Buy |
+75,021
| New | +$1.39M | 0.02% | 542 |
|
Other funds holding VIVO
Marshall Wace's VIVO Position: Q1 2023 in Review
Marshall Wace sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 153,227 shares — an estimated $5.09M sold.
Marshall Wace first reported a position in VIVO in Q2 2015 and held it in 14 quarters. The position peaked at $5.09M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- Marshall Wace reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- Marshall Wace sold 153,227 Meridian Bioscience Inc shares in Q1 2023, an estimated $5.09M.
- Marshall Wace first reported a position in Meridian Bioscience Inc in Q2 2015 and held it in 14 quarters.
- Marshall Wace's Meridian Bioscience Inc position peaked at $5.09M in Q4 2022.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.